Clinical Trial Update: Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating repurposing colchicine to reduce residual inflammatory risk in people with Type 1 diabetes and cardiovascular disease;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Type 1 Diabetes Mellitus

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Asger Lund, MD | Conditions: Type 1 Diabetes, Cardiovascular Diseases | Phase 2 | Status: ACTIVE_NOT_RECRUITING